Discover

HOWL
Werewolf Therapeutics, Inc.
0.35
2 x 0.25
11 x 0.37
bid
ask
-
0.01
1.92%
7 @ 04:00 PM
0.36 +0.00 (0.82%)
Ytd-44.32%
1y-66.38%
0.35
day range
0.37
0.27
52 week range
2.38
Open0.36Prev Close0.36Low0.35High0.37Mkt Cap17.15M
Vol1.36MAvg Vol607.84KEPS-1.21P/EN/AForward P/E-0.86
Beta0.41Short Ratio2.09Inst. Own72.62%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0750-d Avg0.52200-d Avg0.891yr Est12.00
Income Statement
Operating Expenses13.27M
Research and Development Expense8.18M
Selling, General and Administrative Expense5.09M
Operating Income-13.27M
Interest Expense1.37M
Net Income-13.53M
Net Income Common Stock-13.53M
Net Income Common Stock (USD)-13.53M
Consolidated Income-13.53M
Earnings per Basic Share-0.28
Earnings per Basic Share (USD)-0.28
Earnings per Diluted Share-0.28
Earning Before Interest & Taxes (EBIT)-12.16M
Earning Before Interest & Taxes (USD)-12.16M
Weighted Average Shares48.60M
Weighted Average Shares Diluted49.39M
Balance Sheet
Cash and Equivalents46.45M
Cash and Equivalents (USD)46.45M
Current Assets48.73M
Property, Plant & Equipment Net9.29M
Total Assets58.02M
Debt Current30.44M
Total Debt37.65M
Current Liabilities38.52M
Debt Non-Current7.22M
Total Liabilities45.82M
Accumulated Retained Earnings (Deficit)-488.94M
Shareholders Equity12.20M
Shareholders Equity (USD)12.20M
Assets Non-Current9.29M
Total Debt (USD)37.65M
Liabilities Non-Current7.30M
Trade and Non-Trade Payables3.57M
Cash Flow
Depreciation, Amortization & Accretion616.00K
Net Cash Flow / Change in Cash & Cash Equivalents-10.60M
Net Cash Flow from Operations-10.60M
Share Based Compensation929.00K